Issues in the design and implementation of vaccine trials in less developed countries (Q34578596)

3 August 2017

1 reference

title

Issues in the design and implementation of vaccine trials in less developed countries (English)

1 reference

3 August 2017

1 reference

Jacqueline L Deen

1 reference

3 August 2017

John D Clemens

1 reference

3 August 2017

language of work or name

1 reference

1 November 2006

1 reference

Nature Reviews Drug Discovery

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

932-940

1 reference

The introduction of new vaccines into developing countries.

3 August 2017

cites work

1 reference

Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines

21 January 2018

1 reference

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

21 January 2018

1 reference

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

21 January 2018

1 reference

A short report on highlights of world-wide development of RIX4414: a Latin American experience

21 January 2018

1 reference

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

21 January 2018

1 reference

Infectious disease experimentation involving human volunteers

21 January 2018

1 reference

21 January 2018

1 reference

Studies of equivalence in clinical vaccine research

21 January 2018

1 reference

Sample size determination for phase II studies of new vaccines

21 January 2018

1 reference

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

21 January 2018

1 reference

Incidence of hepatitis A in Israel following universal immunization of toddlers

21 January 2018

1 reference

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

21 January 2018

1 reference

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

21 January 2018

1 reference

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

21 January 2018

1 reference

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

21 January 2018

1 reference

The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease?

21 January 2018

1 reference

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

21 January 2018

1 reference

Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy

21 January 2018

1 reference

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects

21 January 2018

1 reference

Child mortality after high-titre measles vaccines: prospective study in Senegal

21 January 2018

1 reference

The Good Clinical Practice guideline: a bronze standard for clinical research.

21 January 2018

1 reference

Clinical trials, consensus conferences, and clinical practice

21 January 2018

1 reference

Research involving human subjects in developing countries.

21 January 2018

1 reference

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

21 January 2018

1 reference

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

21 January 2018

1 reference

Sustainable introduction of affordable new vaccines: the targeting strategy

21 January 2018

1 reference

Introducing new vaccines into developing countries: obstacles, opportunities and complexities

31 March 2020

1 reference

HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial

31 March 2020

1 reference

The ethical challenge of infection-inducing challenge experiments

31 March 2020

1 reference

Showing a treatment is good because it is not bad: when does "noninferiority" imply effectiveness?

31 March 2020

1 reference

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

31 March 2020

1 reference

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

31 March 2020

1 reference

Prelicensure evaluation of combination vaccines

31 March 2020

1 reference

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults

31 March 2020

1 reference

Hib vaccines for all the world's children?

31 March 2020

1 reference

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

31 March 2020

1 reference

Ethical issues for collaborative research in developing countries

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD2159

1 reference

Dimensions Publication ID

3 August 2017

1018772699

0 references

1 reference